DREADD
Designer receptors exclusively activated by designer drugs (DREADDs) are genetically engineered GPCRs that are activated by physiologically inert synthetic small molecules (designer drugs) but not their endogenous ligand. Read our DREADDs mini-review or for practical advice on using these ligands in the lab see Stability of Water-Soluble DREADD Ligands in Solution: A Technical Review and Clozapine N-Oxide (freebase) - a technical review on stability, solubility and use in the lab).
-
-
epi-Aszonalenin A (HB3889)
Description:Derivative of aszonalenin, a substance P inhibitor.
Purity:>95%
-
Epirubicin hydrochloride (HB4187)
Description:DNA synthesis and function inhibitor. Inhbits DNA topoisomerase II
Purity:>98%
-
-
Epoxomicin (HB3890)
Description:Potent, selective and irreversible 20S proteasome inhibitor
Purity:>97%
-
Eremofortin B (HB3892)
Description:Eremophilane sesquiterpene. Nontoxic secondary metabolite from Penicillium roqueforti.
Purity:>98%
- Description:
Sphingosine 1-phosphate (S1P/EDG) receptors analog
Purity:>98%
